메뉴 건너뛰기




Volumn 31, Issue 1, 2014, Pages 1-47

Tiny technology proves big: A challenge at engineering, medicine and pharmaceutical sciences interface

Author keywords

Diagnostic agents; Nanomedicine; Polymeric nanoparticles; Targeted drug delivery; Therapy

Indexed keywords

ALBUMIN NANOPARTICLE; ALGINIC ACID; APTAMER; CARBON NANOTUBE; CHITOSAN; COLLOIDAL NANOLIOSOME; CYANOACRYLATE DERIVATIVE; CYCLODEXTRIN NANOPARTICLE; DENDRIMER; GELATIN; GLIADIN; GOLD NANOPARTICLE; MAGNETIC NANOPARTICLE; METAL NANOPARTICLE; METALOXIDE NANOPARTICLE; MONOCLONAL ANTIBODY; NANOCARRIER; NANOGEL; NANOPARTICLE; PHOSPHOLIPID; POLYANHYDRIDE; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIDE; POLYMER; PULLULAN; QUANTUM DOT; SOLID LIPID NANOPARTICLE; STREPTAVIDIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 84897597790     PISSN: 07434863     EISSN: 2162660X     Source Type: Journal    
DOI: 10.1615/CritRevTherDrugCarrierSyst.2013007914     Document Type: Review
Times cited : (13)

References (166)
  • 1
    • 77957342857 scopus 로고    scopus 로고
    • Nanotechnology: What is it and why is small so big?
    • Leary JF. Nanotechnology: what is it and why is small so big? Can J Ophthalmol. 2010; 45: 449-56.
    • (2010) Can J Ophthalmol. , vol.45 , pp. 449-456
    • Leary, J.F.1
  • 2
    • 0002982888 scopus 로고
    • There's plenty of room at the bottom
    • Feynman R. There's plenty of room at the bottom. Eng Sci. 1960; 23: 22-36.
    • (1960) Eng Sci. , vol.23 , pp. 22-36
    • Feynman, R.1
  • 3
  • 6
    • 9644303156 scopus 로고    scopus 로고
    • In vitro degradation of nanoparticles prepared from polymers based on dllactide, glycolide and poly (ethylene oxide)
    • Zweers ML, Engbers GH, Grijpma DW, Feijen J. In vitro degradation of nanoparticles prepared from polymers based on dllactide, glycolide and poly (ethylene oxide). J Control Release. 2004; 100: 347-56.
    • (2004) J Control Release. , vol.100 , pp. 347-356
    • Zweers, M.L.1    Engbers, G.H.2    Grijpma, D.W.3    Feijen, J.4
  • 7
    • 2442716075 scopus 로고    scopus 로고
    • Poly-epsilon caprolactone microspheres and nanospheres: An overview
    • Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-epsilon caprolactone microspheres and nanospheres: an overview. Int J Pharm. 2004; 278: 1-23.
    • (2004) Int J Pharm. , vol.278 , pp. 1-23
    • Sinha, V.R.1    Bansal, K.2    Kaushik, R.3    Kumria, R.4    Trehan, A.5
  • 8
    • 4844220950 scopus 로고    scopus 로고
    • Design and characterisation of new nanoparticulate polymer blends for drug delivery
    • Csaba N, Gonzalez L, Sanchez A, Alonso MJ. Design and characterisation of new nanoparticulate polymer blends for drug delivery. J Biomater Sci Polym Ed. 2004; 15: 1137-51.
    • (2004) J Biomater Sci Polym Ed. , vol.15 , pp. 1137-1151
    • Csaba, N.1    Gonzalez, L.2    Sanchez, A.3    Alonso, M.J.4
  • 9
    • 15044348714 scopus 로고    scopus 로고
    • Poly (ethylene oxide)-modified poly (epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifenin breast cancer
    • Shenoy DB, Amiji MM. Poly (ethylene oxide)-modified poly (epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifenin breast cancer. Int J Pharm. 2005; 293: 261-70.
    • (2005) Int J Pharm. , vol.293 , pp. 261-270
    • Shenoy, D.B.1    Amiji, M.M.2
  • 10
    • 33947303063 scopus 로고    scopus 로고
    • Characterization of bio-nanocapsule as a transfer vector targeting human hepatocyte carcinoma by disulfide linkage modification
    • Nagaoka T, Fukuda T, Yoshida S, Nishimura H, Yu D, Kuroda S. Characterization of bio-nanocapsule as a transfer vector targeting human hepatocyte carcinoma by disulfide linkage modification. J Control Release. 2007; 118: 348-56.
    • (2007) J Control Release. , vol.118 , pp. 348-356
    • Nagaoka, T.1    Fukuda, T.2    Yoshida, S.3    Nishimura, H.4    Yu, D.5    Kuroda, S.6
  • 11
    • 75149159453 scopus 로고    scopus 로고
    • Development of bio-nanocapsules and its applications in the biomedical field
    • Sunichi K, Takeshi K, Sunichi K, Joohee J, Katsuyuki T. Development of bio-nanocapsules and its applications in the biomedical field. Chem Ind. 2006; 57: 869-74.
    • (2006) Chem Ind. , vol.57 , pp. 869-874
    • Sunichi, K.1    Takeshi, K.2    Sunichi, K.3    Joohee, J.4    Katsuyuki, T.5
  • 12
    • 39649101074 scopus 로고    scopus 로고
    • Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials
    • Jung J, Matsuzaki T, Tatematsu K, Okajima T, Tanizawa K, Kuroda S. Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials. J Control Release. 2008; 126: 255-64.
    • (2008) J Control Release. , vol.126 , pp. 255-264
    • Jung, J.1    Matsuzaki, T.2    Tatematsu, K.3    Okajima, T.4    Tanizawa, K.5    Kuroda, S.6
  • 13
    • 0020304046 scopus 로고
    • Acid-base interactions in polymer adhesion
    • Fowkes FM. Acid-base interactions in polymer adhesion. Tribology series. 1981. Vol. 7., p. 119-137.
    • (1981) Tribology series , vol.7 , pp. 119-137
    • Fowkes, F.M.1
  • 14
    • 79957691069 scopus 로고    scopus 로고
    • Physical and chemical stability of drug nanoparticles
    • Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Del Rev. 2011; 63: 456-69.
    • (2011) Adv Drug Del Rev. , vol.63 , pp. 456-469
    • Wu, L.1    Zhang, J.2    Watanabe, W.3
  • 15
    • 79957692320 scopus 로고    scopus 로고
    • Formation, characterization, and fate of inhaled drug nanoparticles
    • Zhang J, Wu L, Chan H-K, Watanabe W. Formation, characterization, and fate of inhaled drug nanoparticles. Adv Drug Del Rev. 2011; 63: 441-55.
    • (2011) Adv Drug Del Rev. , vol.63 , pp. 441-455
    • Zhang, J.1    Wu, L.2    Chan, H.-K.3    Watanabe, W.4
  • 16
    • 34548542955 scopus 로고    scopus 로고
    • Nanoparticles production by supercritical antisolvent precipitation: A general interpretation
    • Reverchon E, De Marco I, Torino E. Nanoparticles production by supercritical antisolvent precipitation: a general interpretation. J Supercrit Fluid. 2007; 43: 126-38.
    • (2007) J Supercrit Fluid. , vol.43 , pp. 126-138
    • Reverchon, E.1    De Marco, I.2    Torino, E.3
  • 17
    • 79957768993 scopus 로고    scopus 로고
    • Production methods for nanodrug particles using the bottom-up approach
    • Chan HK, Kwok PCL. Production methods for nanodrug particles using the bottom-up approach. Adv Drug Del Rev. 2011; 63: 406-16.
    • (2011) Adv Drug Del Rev. , vol.63 , pp. 406-416
    • Chan, H.K.1    Kwok, P.C.L.2
  • 20
    • 42649125889 scopus 로고    scopus 로고
    • Inhaled nanoparticles-a current review
    • Yang W, Peters JI, Williams RO. Inhaled nanoparticles-a current review. Int J Pharm. 2008; 356: 239-47.
    • (2008) Int J Pharm. , vol.356 , pp. 239-247
    • Yang, W.1    Peters, J.I.2    Williams, R.O.3
  • 21
    • 78249234246 scopus 로고    scopus 로고
    • Nanoparticle interface: An important determinant in nanoparticlemediated drug/gene delivery
    • Gupta RB, Kompella UB, Editors
    • Sahoo SK, Labhasetwar V. Nanoparticle interface: an important determinant in nanoparticlemediated drug/gene delivery. Gupta RB, Kompella UB, Editors. Nanoparticle technology for drug delivery. 2006. Vol. 159. p. 139-43.
    • (2006) Nanoparticle technology for drug delivery , vol.159 , pp. 139-143
    • Sahoo, S.K.1    Labhasetwar, V.2
  • 22
    • 75549087162 scopus 로고    scopus 로고
    • Nanosystem drug targeting: Facing up to complex realities
    • Ruenraroengsak P, Cook JM, Florence AT. Nanosystem drug targeting: facing up to complex realities. J Control Rel. 2010; 141: 265-76.
    • (2010) J Control Rel. , vol.141 , pp. 265-276
    • Ruenraroengsak, P.1    Cook, J.M.2    Florence, A.T.3
  • 24
    • 75149175575 scopus 로고    scopus 로고
    • Colloidal nanocarriers: A review on formulation technology, types and applications toward targeted drug delivery
    • Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine: NBM 2010; 6: 9-24.
    • (2010) Nanomedicine: NBM , vol.6 , pp. 9-24
    • Mishra, B.1    Patel, B.B.2    Tiwari, S.3
  • 26
    • 33745482218 scopus 로고    scopus 로고
    • A genetic algorithm-based area coverage approach for controlled drug delivery using microrobots
    • Tao WM, Zhang M. A genetic algorithm-based area coverage approach for controlled drug delivery using microrobots. Nanomedicine. 2005; 1: 91-100.
    • (2005) Nanomedicine. , vol.1 , pp. 91-100
    • Tao, W.M.1    Zhang, M.2
  • 27
    • 0034996764 scopus 로고    scopus 로고
    • Long-circulating and target specific nanoparticles: Theory to practice
    • Moghimi SM, Hunter AC, Murray JC. Long-circulating and target specific nanoparticles: theory to practice. Pharmacol Rev. 2001; 53: 283-318.
    • (2001) Pharmacol Rev. , vol.53 , pp. 283-318
    • Moghimi, S.M.1    Hunter, A.C.2    Murray, J.C.3
  • 28
    • 2342471420 scopus 로고    scopus 로고
    • The blood-brain barrier: An overview: Structure, regulation, and clinical implications
    • Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004; 16: 1-13.
    • (2004) Neurobiol Dis. , vol.16 , pp. 1-13
    • Ballabh, P.1    Braun, A.2    Nedergaard, M.3
  • 29
    • 0034000453 scopus 로고    scopus 로고
    • Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review
    • Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000; 65: 271-84.
    • (2000) J Control Release. , vol.65 , pp. 271-284
    • Maeda, H.1    Wu, J.2    Sawa, T.3    Matsumura, Y.4    Hori, K.5
  • 30
    • 47749124567 scopus 로고    scopus 로고
    • Preparation of sodium deoxycholate (DOC) conjugated heparin derivatives for inhibition of angiogenesis and cancer cell growth
    • Cho KJ, Moon HT, Park GE, Jeon OC, Byun Y, Lee YK. Preparation of sodium deoxycholate (DOC) conjugated heparin derivatives for inhibition of angiogenesis and cancer cell growth. Bioconjug Chem. 2008; 19: 1346-51.
    • (2008) Bioconjug Chem. , vol.19 , pp. 1346-1351
    • Cho, K.J.1    Moon, H.T.2    Park, G.E.3    Jeon, O.C.4    Byun, Y.5    Lee, Y.K.6
  • 31
    • 41249099944 scopus 로고    scopus 로고
    • New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting
    • Chytil P, Etrych T, Konak C, Sirova M, Mrkvan T, Boucek J. New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting. J Control Release. 2008; 127: 121-30.
    • (2008) J Control Release. , vol.127 , pp. 121-130
    • Chytil, P.1    Etrych, T.2    Konak, C.3    Sirova, M.4    Mrkvan, T.5    Boucek, J.6
  • 32
    • 40649100957 scopus 로고    scopus 로고
    • Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor bearing mice
    • Kim JH, Kim YS, Park K, Lee S, Nam HY, Min KH. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor bearing mice. J Control Release. 2008; 127: 41-9.
    • (2008) J Control Release. , vol.127 , pp. 41-49
    • Kim, J.H.1    Kim, Y.S.2    Park, K.3    Lee, S.4    Nam, H.Y.5    Min, K.H.6
  • 33
    • 24144490885 scopus 로고    scopus 로고
    • Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention
    • Sahoo SK, Labhasetwar V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm. 2005; 2: 373-83.
    • (2005) Mol Pharm. , vol.2 , pp. 373-383
    • Sahoo, S.K.1    Labhasetwar, V.2
  • 34
    • 12944304157 scopus 로고    scopus 로고
    • Selection of aptamers with high affinity and high specificity against C595, ananti-MUC1 IgG3 monoclonal antibody, for antibody targeting
    • Missailidis S, Thomaidou D, Borbas KE, Price MR. Selection of aptamers with high affinity and high specificity against C595, ananti-MUC1 IgG3 monoclonal antibody, for antibody targeting. J Immunol Methods. 2005; 296: 45-62.
    • (2005) J Immunol Methods. , vol.296 , pp. 45-62
    • Missailidis, S.1    Thomaidou, D.2    Borbas, K.E.3    Price, M.R.4
  • 35
    • 0034866792 scopus 로고    scopus 로고
    • Liposomes bearing polyethyleneglycol-coupledtransferrin with intracellular targeting property to the solid tumors in vivo
    • Ishida O, Maruyama K, Tanahashi H, Iwatsuru M, Sasaki K, Eriguchi M. Liposomes bearing polyethyleneglycol-coupledtransferrin with intracellular targeting property to the solid tumors in vivo. Pharm Res. 2001; 18: 1042-8.
    • (2001) Pharm Res. , vol.18 , pp. 1042-1048
    • Ishida, O.1    Maruyama, K.2    Tanahashi, H.3    Iwatsuru, M.4    Sasaki, K.5    Eriguchi, M.6
  • 37
    • 3843112386 scopus 로고    scopus 로고
    • Current methods for attaching targeting ligands to liposomes and nanoparticles
    • Nobs L, Buchegger F, Gurny R, Allemann E. Current methods for attaching targeting ligands to liposomes and nanoparticles. J Pharm Sci. 2004; 93: 1980-92.
    • (2004) J Pharm Sci. , vol.93 , pp. 1980-1992
    • Nobs, L.1    Buchegger, F.2    Gurny, R.3    Allemann, E.4
  • 38
    • 0842311621 scopus 로고    scopus 로고
    • Vascular targeting agents as cancer therapeutics
    • Thorpe PE. Vascular targeting agents as cancer therapeutics. Clin Cancer Res. 2004; 10: 415-27.
    • (2004) Clin Cancer Res. , vol.10 , pp. 415-427
    • Thorpe, P.E.1
  • 39
    • 0032525740 scopus 로고    scopus 로고
    • Tumor vasculature targeted therapies: Getting the players organized
    • Molema G, Meijer DK, de Leij LF. Tumor vasculature targeted therapies: getting the players organized. Biochem Pharmacol. 1998; 55: 1939-45.
    • (1998) Biochem Pharmacol. , vol.55 , pp. 1939-1945
    • Molema, G.1    Meijer, D.K.2    de Leij, L.F.3
  • 40
    • 75749088450 scopus 로고    scopus 로고
    • Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
    • Choi CH, Alabi CA, Webster P, Davis ME. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc Natl Acad Sci USA. 2010; 107: 1235-40.
    • (2010) Proc Natl Acad Sci USA. , vol.107 , pp. 1235-1240
    • Choi, C.H.1    Alabi, C.A.2    Webster, P.3    Davis, M.E.4
  • 41
    • 34249894977 scopus 로고    scopus 로고
    • Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody
    • Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release. 2007; 120: 18-26.
    • (2007) J Control Release. , vol.120 , pp. 18-26
    • Kocbek, P.1    Obermajer, N.2    Cegnar, M.3    Kos, J.4    Kristl, J.5
  • 42
    • 76749138904 scopus 로고    scopus 로고
    • The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cells
    • Tong R, Yala L, Fan TM, Cheng J. The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cells. Biomaterials. 2010; 31: 3043-53.
    • (2010) Biomaterials. , vol.31 , pp. 3043-3053
    • Tong, R.1    Yala, L.2    Fan, T.M.3    Cheng, J.4
  • 43
    • 0025194307 scopus 로고
    • Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase
    • Gold L, Tuerk C. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990; 249: 505-10.
    • (1990) Science. , vol.249 , pp. 505-510
    • Gold, L.1    Tuerk, C.2
  • 46
    • 0037072555 scopus 로고    scopus 로고
    • Folate-mediated delivery of macromolecular anticancer therapeutic agents
    • Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev. 2002; 54: 675-93.
    • (2002) Adv Drug Deliv Rev. , vol.54 , pp. 675-693
    • Lu, Y.1    Low, P.S.2
  • 47
    • 0343882023 scopus 로고    scopus 로고
    • Targeted drug delivery via the folate receptor
    • Sudimack JBA, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev. 2000; 41: 147-62.
    • (2000) Adv Drug Deliv Rev. , vol.41 , pp. 147-162
    • Sudimack, J.B.A.1    Lee, R.J.2
  • 48
    • 0016756272 scopus 로고
    • Continuous culture of fused cell secreting antibody of predefined specificity
    • Kohler G, Milstein C. Continuous culture of fused cell secreting antibody of predefined specificity. Nature. 1975; 256: 495-7.
    • (1975) Nature. , vol.256 , pp. 495-497
    • Kohler, G.1    Milstein, C.2
  • 49
    • 33744986992 scopus 로고    scopus 로고
    • Trastuzumab modified nanoparticles: Optimisation of preparation and uptake in cancer cells
    • Steinhauser I, Spankuch B, Strebhardt K, Langer K. Trastuzumab modified nanoparticles: optimisation of preparation and uptake in cancer cells. Biomaterials. 2006; 27: 4975-83.
    • (2006) Biomaterials. , vol.27 , pp. 4975-4983
    • Steinhauser, I.1    Spankuch, B.2    Strebhardt, K.3    Langer, K.4
  • 50
    • 33745495366 scopus 로고    scopus 로고
    • A review: Integrin αvβ3-targeted molecular imaging and therapy in angiogenesis
    • Lim EH, Danthi TN, Bednarski M, Li KCP. A review: integrin αvβ3-targeted molecular imaging and therapy in angiogenesis. Nanomedicine. 2005; 1: 110-4.
    • (2005) Nanomedicine. , vol.1 , pp. 110-114
    • Lim, E.H.1    Danthi, T.N.2    Bednarski, M.3    Li, K.C.P.4
  • 51
    • 34249327294 scopus 로고    scopus 로고
    • Targeted pharmaceutical nanocarriers for cancer therapy and imaging
    • Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J. 2007; 9: 128-47.
    • (2007) AAPS J. , vol.9 , pp. 128-147
    • Torchilin, V.P.1
  • 52
    • 4444379133 scopus 로고    scopus 로고
    • Nanoparticle and targeted systems for cancer therapy
    • Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004; 56: 1649-59.
    • (2004) Adv Drug Deliv Rev. , vol.56 , pp. 1649-1659
    • Brannon-Peppas, L.1    Blanchette, J.O.2
  • 53
  • 54
    • 11844250522 scopus 로고    scopus 로고
    • Poly (amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide
    • Vandamme TF, Brobeck L. Poly (amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J Control Release. 2005; 102 (1): 23-38.
    • (2005) J Control Release. , vol.102 , Issue.1 , pp. 23-38
    • Vandamme, T.F.1    Brobeck, L.2
  • 56
    • 0346848865 scopus 로고    scopus 로고
    • Nanotech approaches to drug delivery and imaging
    • Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today. 2003; 8: 1112-20.
    • (2003) Drug Discov Today. , vol.8 , pp. 1112-1120
    • Sahoo, S.K.1    Labhasetwar, V.2
  • 57
    • 0033041992 scopus 로고    scopus 로고
    • Sterically stabilized liposomes in cancer therapy and gene delivery
    • Lasic DD. Sterically stabilized liposomes in cancer therapy and gene delivery. Curr Opin Mol Ther. 1999; 1: 177-85.
    • (1999) Curr Opin Mol Ther. , vol.1 , pp. 177-185
    • Lasic, D.D.1
  • 58
    • 0021734435 scopus 로고
    • Increased circulatory half-life of liposomes after conjugation with dextran
    • Pain D, Das PK, Ghosh PC, Bachhawat BK. Increased circulatory half-life of liposomes after conjugation with dextran. J Biosci. 1984; 6: 811-6.
    • (1984) J Biosci. , vol.6 , pp. 811-816
    • Pain, D.1    Das, P.K.2    Ghosh, P.C.3    Bachhawat, B.K.4
  • 60
    • 0032950389 scopus 로고    scopus 로고
    • Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain
    • Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release. 1999; 59: 299-307.
    • (1999) J Control Release. , vol.59 , pp. 299-307
    • Yang, S.C.1    Lu, L.F.2    Cai, Y.3    Zhu, J.B.4    Liang, B.W.5    Yang, C.Z.6
  • 61
    • 0036153138 scopus 로고    scopus 로고
    • Production of solid lipid nanoparticles (SLN): Scaling up feasibilities
    • Dingler A, Gohla S. Production of solid lipid nanoparticles (SLN): scaling up feasibilities. J Microencapsul. 2002; 19: 11-6.
    • (2002) J Microencapsul. , vol.19 , pp. 11-16
    • Dingler, A.1    Gohla, S.2
  • 62
    • 0035984818 scopus 로고    scopus 로고
    • Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: Pharmacokinetics and distribution of doxorubicin in brain and other tissues
    • Zara GP, Cavalli R, Bargoni A, Fundaro A, Vighetto D, Gasco MR. Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues. J Drug Target. 2002; 10: 327-35.
    • (2002) J Drug Target. , vol.10 , pp. 327-335
    • Zara, G.P.1    Cavalli, R.2    Bargoni, A.3    Fundaro, A.4    Vighetto, D.5    Gasco, M.R.6
  • 63
    • 77955434240 scopus 로고    scopus 로고
    • Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages
    • Yu W, Liu C, Liu Y, Zhang N, Xu W. Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res. 2010; 8: 1584-96.
    • (2010) Pharm Res. , vol.8 , pp. 1584-1596
    • Yu, W.1    Liu, C.2    Liu, Y.3    Zhang, N.4    Xu, W.5
  • 64
    • 1942453805 scopus 로고    scopus 로고
    • Solid lipid nanoparticles for parenteral drug delivery
    • Wissing SA, Kayser O, Muller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 2004; 56: 1257-72.
    • (2004) Adv Drug Deliv Rev. , vol.56 , pp. 1257-1272
    • Wissing, S.A.1    Kayser, O.2    Muller, R.H.3
  • 65
    • 0033800767 scopus 로고    scopus 로고
    • Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: Pharmacokinetics and tissue distribution after i. v. administration to rats
    • Fundaro A, Cavalli R, Bargoni A, Vighetto D, Zara GP, Gasco MR. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i. v. administration to rats. Pharmacol Res. 2000; 42: 337-43.
    • (2000) Pharmacol Res. , vol.42 , pp. 337-343
    • Fundaro, A.1    Cavalli, R.2    Bargoni, A.3    Vighetto, D.4    Zara, G.P.5    Gasco, M.R.6
  • 66
    • 0033976172 scopus 로고    scopus 로고
    • Solid lipid nanoparticles as drug carriers for topical glucocorticoids
    • Maia CS, Mehnert W, Schafer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm. 2000; 196: 165-7.
    • (2000) Int J Pharm. , vol.196 , pp. 165-167
    • Maia, C.S.1    Mehnert, W.2    Schafer-Korting, M.3
  • 67
    • 38349173816 scopus 로고    scopus 로고
    • Microemulsions containing lecithin and sugar-based surfactants: Nanoparticle templates for delivery of proteins and peptides
    • Graf A, Ablinger E, Peters S, Zimmer A, Hook S, Rades T. Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides. Int J Pharma. 2008; 350: 351-60.
    • (2008) Int J Pharma. , vol.350 , pp. 351-360
    • Graf, A.1    Ablinger, E.2    Peters, S.3    Zimmer, A.4    Hook, S.5    Rades, T.6
  • 68
    • 33745494861 scopus 로고    scopus 로고
    • Camptothecin in sterically stabilized phospholipid micelles: A novel nanomedicine
    • Koo OM, Rubinstein I, Onyuksel H. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine. Nanomedicine. 2005; 1: 77-84.
    • (2005) Nanomedicine. , vol.1 , pp. 77-84
    • Koo, O.M.1    Rubinstein, I.2    Onyuksel, H.3
  • 69
    • 67349244438 scopus 로고    scopus 로고
    • Quantum dots encapsulated in phospholipid micelles for imaging and quantification of tumors in the near-infrared region
    • Papagiannaros A, Levchenko T, Hartner W, Mongayt D, Torchilin V. Quantum dots encapsulated in phospholipid micelles for imaging and quantification of tumors in the near-infrared region. Nanomedicine. 2009; 5: 2: 216-24.
    • (2009) Nanomedicine. , vol.5 , Issue.2 , pp. 216-224
    • Papagiannaros, A.1    Levchenko, T.2    Hartner, W.3    Mongayt, D.4    Torchilin, V.5
  • 70
    • 0141886987 scopus 로고    scopus 로고
    • Drug delivery in polymeric micelles: From in vitro to in vivo
    • Rapoport N, Pitt WG, Sun H, Nelson JL. Drug delivery in polymeric micelles: from in vitro to in vivo. J Control Release. 2003; 91: 85-95.
    • (2003) J Control Release. , vol.91 , pp. 85-95
    • Rapoport, N.1    Pitt, W.G.2    Sun, H.3    Nelson, J.L.4
  • 71
    • 0032531663 scopus 로고    scopus 로고
    • Non-ionic surfactant based vesicles (niosomes) in drug delivery
    • Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998; 172: 33-70.
    • (1998) Int J Pharm. , vol.172 , pp. 33-70
    • Uchegbu, I.F.1    Vyas, S.P.2
  • 72
    • 27844529489 scopus 로고    scopus 로고
    • Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide
    • Guinedi AS, Mortada ND, Mansour S, Hathout RM. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 2005; 306: 71-82.
    • (2005) Int J Pharm. , vol.306 , pp. 71-82
    • Guinedi, A.S.1    Mortada, N.D.2    Mansour, S.3    Hathout, R.M.4
  • 73
    • 39649120532 scopus 로고    scopus 로고
    • A review of stimuli responsive nanocarriers for drug and gene delivery
    • Ganta S, Devalapally H, Shahiwala A, Amiji M. A review of stimuli responsive nanocarriers for drug and gene delivery. J Control Release. 2008; 126: 187-204.
    • (2008) J Control Release. , vol.126 , pp. 187-204
    • Ganta, S.1    Devalapally, H.2    Shahiwala, A.3    Amiji, M.4
  • 74
    • 26944492164 scopus 로고    scopus 로고
    • Polymeric micelles with a pH-responsive structure as intracellular drug carriers
    • Wang CH, Hsiue GH. Polymeric micelles with a pH-responsive structure as intracellular drug carriers. J Control Release. 2005; 108: 140-9.
    • (2005) J Control Release. , vol.108 , pp. 140-149
    • Wang, C.H.1    Hsiue, G.H.2
  • 75
    • 33748870763 scopus 로고    scopus 로고
    • Molecular design of biodegradable polymeric micelles for temperature responsive drug release
    • Nakayama M, Okano T, Miyazaki T, Kohori F, Sakai K, Yokoyama M. Molecular design of biodegradable polymeric micelles for temperature responsive drug release. J Control Release. 2006; 115: 46-56.
    • (2006) J Control Release. , vol.115 , pp. 46-56
    • Nakayama, M.1    Okano, T.2    Miyazaki, T.3    Kohori, F.4    Sakai, K.5    Yokoyama, M.6
  • 76
    • 81355138643 scopus 로고    scopus 로고
    • Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy
    • Satya P Satya P, Meenakshi M, Wei S, Catherine TD, Sana A. Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy. Adv Drug Deliv. 2011; 63: 1340-51.
    • (2011) Adv Drug Deliv. , vol.63 , pp. 1340-1351
    • Satya, P.1    Satya, P.2    Meenakshi, M.3    Wei, S.4    Catherine, T.D.5    Sana, A.6
  • 77
    • 33845378981 scopus 로고
    • Cascade molecules: A new approach to micelles, A[27]-Arborol
    • Newkome GR, Yao Z, Baker GR, Gupta VK. Cascade molecules: a new approach to micelles, A[27]-Arborol. J Org Chem. 1985; 50: 2003-4.
    • (1985) J Org Chem. , vol.50 , pp. 2003-2004
    • Newkome, G.R.1    Yao, Z.2    Baker, G.R.3    Gupta, V.K.4
  • 78
    • 0031751919 scopus 로고    scopus 로고
    • Preparation and characterization of thermally responsive block copolymer micelles comprising poly (N-isopropylacrylamide-b-DLlactide)
    • Kohori F, Sakai K, Aoyagi T, Yokoyama M, Sakurai Y, Okano T. Preparation and characterization of thermally responsive block copolymer micelles comprising poly (N-isopropylacrylamide-b-DLlactide). J Control Release. 1998; 55: 87-98.
    • (1998) J Control Release. , vol.55 , pp. 87-98
    • Kohori, F.1    Sakai, K.2    Aoyagi, T.3    Yokoyama, M.4    Sakurai, Y.5    Okano, T.6
  • 80
    • 0141921483 scopus 로고    scopus 로고
    • Polymeric micelle for tumor pH and folate mediated targeting
    • Lee ES, Na K, Bae YH. Polymeric micelle for tumor pH and folate mediated targeting. J Control Release. 2003; 91: 103-13.
    • (2003) J Control Release. , vol.91 , pp. 103-113
    • Lee, E.S.1    Na, K.2    Bae, Y.H.3
  • 81
    • 0035850224 scopus 로고    scopus 로고
    • Structure and design of polymeric surfactant-based drug delivery systems
    • Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2001; 73: 137-72.
    • (2001) J Control Release. , vol.73 , pp. 137-172
    • Torchilin, V.P.1
  • 82
    • 0035994313 scopus 로고    scopus 로고
    • Optimizing pH-responsive polymeric micelles for drug delivery in a cancer photodynamic therapy model
    • Le Garrec D, Taillefer J, Van Lier JE, Lenaerts V, Leroux JC. Optimizing pH-responsive polymeric micelles for drug delivery in a cancer photodynamic therapy model. J Drug Target. 2002; 10: 429-37.
    • (2002) J Drug Target. , vol.10 , pp. 429-437
    • Le Garrec, D.1    Taillefer, J.2    Van Lier, J.E.3    Lenaerts, V.4    Leroux, J.C.5
  • 83
    • 84855824016 scopus 로고    scopus 로고
    • Nanoparticles: A boon to drug delivery, therapeutics, diagnostics and imaging
    • Parveen S, Misra R, Sahoo S K. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanotech Nanomed Biol Med. 2012; 8: 147-66.
    • (2012) Nanotech Nanomed Biol Med. , vol.8 , pp. 147-166
    • Parveen, S.1    Misra, R.2    Sahoo, S.K.3
  • 84
    • 0025874282 scopus 로고
    • Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood
    • Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 1991; 51: 3229-36.
    • (1991) Cancer Res. , vol.51 , pp. 3229-3236
    • Yokoyama, M.1    Okano, T.2    Sakurai, Y.3    Ekimoto, H.4    Shibazaki, C.5    Kataoka, K.6
  • 85
    • 0036096946 scopus 로고    scopus 로고
    • Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel
    • Ibrahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res. 2002; 8: 1038-44.
    • (2002) Clin Cancer Res. , vol.8 , pp. 1038-1044
    • Ibrahim, N.K.1    Desai, N.2    Legha, S.3    Soon-Shiong, P.4    Theriault, R.L.5    Rivera, E.6
  • 86
    • 14644439267 scopus 로고    scopus 로고
    • Cancer nanotechnology: Opportunities and challenges
    • Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005; 5: 161-71.
    • (2005) Nat Rev Cancer. , vol.5 , pp. 161-171
    • Ferrari, M.1
  • 91
    • 33845248415 scopus 로고    scopus 로고
    • Smart PEGylated gold nanoparticles for the cytoplasmic delivery of siRNA to induce enhanced gene silencing
    • Oishi M, Nakaogami J, Ishii T, Nagasaki Y. Smart PEGylated gold nanoparticles for the cytoplasmic delivery of siRNA to induce enhanced gene silencing. Chem Lett. 2006; 35: 1046-7.
    • (2006) Chem Lett. , vol.35 , pp. 1046-1047
    • Oishi, M.1    Nakaogami, J.2    Ishii, T.3    Nagasaki, Y.4
  • 92
    • 34250835820 scopus 로고    scopus 로고
    • Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin
    • Bhumkar DR, Joshi HM, Sastry M, Pokharkar VB. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res. 2007; 24: 1415-26.
    • (2007) Pharm Res. , vol.24 , pp. 1415-1426
    • Bhumkar, D.R.1    Joshi, H.M.2    Sastry, M.3    Pokharkar, V.B.4
  • 94
    • 30344469072 scopus 로고    scopus 로고
    • Gold nanoparticles as carriers for efficient transmucosal insulin delivery
    • Joshi HM, Bhumkar DR, Joshi K, Pokharkar V, Sastry M. Gold nanoparticles as carriers for efficient transmucosal insulin delivery. Langmuir. 2006; 22: 300-5.
    • (2006) Langmuir. , vol.22 , pp. 300-305
    • Joshi, H.M.1    Bhumkar, D.R.2    Joshi, K.3    Pokharkar, V.4    Sastry, M.5
  • 95
    • 34547441163 scopus 로고    scopus 로고
    • The enhancement effect of gold nanoparticles in drug delivery and as biomarkers of drug-resistant cancer cells
    • Li J, Wang X, Wang C, Chen B, Dai Y, Zhang R, Song M, Lv G, Fu D. The enhancement effect of gold nanoparticles in drug delivery and as biomarkers of drug-resistant cancer cells. Chem Med Chem. 2007; 2: 374-8.
    • (2007) Chem Med Chem. , vol.2 , pp. 374-378
    • Li, J.1    Wang, X.2    Wang, C.3    Chen, B.4    Dai, Y.5    Zhang, R.6    Song, M.7    Lv, G.8    Fu, D.9
  • 96
    • 77953642466 scopus 로고    scopus 로고
    • Multifunctionalized gold nanoparticles with peptides targeted to gastrin-releasing peptide receptor of a tumor cell line
    • Hosta-Rigau L, Olmedo I, Arbiol J, Cruz LJ, Kogan MJ, Albericio F. Multifunctionalized gold nanoparticles with peptides targeted to gastrin-releasing peptide receptor of a tumor cell line. Bioconjug Chem. 2010; 21: 1070-8.
    • (2010) Bioconjug Chem. , vol.21 , pp. 1070-1078
    • Hosta-Rigau, L.1    Olmedo, I.2    Arbiol, J.3    Cruz, L.J.4    Kogan, M.J.5    Albericio, F.6
  • 98
    • 0038202316 scopus 로고    scopus 로고
    • Ceramic-based nanoparticles entrapping water insoluble photosensitizing anticancer drugs: A novel drug-carrier system for photodynamic therapy
    • Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ, Prasad PN. Ceramic-based nanoparticles entrapping water insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc. 2003; 125: 7860-5.
    • (2003) J Am Chem Soc. , vol.125 , pp. 7860-7865
    • Roy, I.1    Ohulchanskyy, T.Y.2    Pudavar, H.E.3    Bergey, E.J.4    Oseroff, A.R.5    Morgan, J.6    Dougherty, T.J.7    Prasad, P.N.8
  • 99
    • 67649364172 scopus 로고    scopus 로고
    • Future perspectives of resin-based dental materials
    • Janet KD, Sigusch BW. Future perspectives of resin-based dental materials. Dent Mater. 2009; 25: 1001-6.
    • (2009) Dent Mater. , vol.25 , pp. 1001-1006
    • Janet, K.D.1    Sigusch, B.W.2
  • 100
    • 70249083223 scopus 로고    scopus 로고
    • Diabetic delayed wound healing and the role of silver nanoparticles
    • Mishra M, Kumar H, Tripathi K. Diabetic delayed wound healing and the role of silver nanoparticles. Dig J Nanomat Biostruct. 2008; 3: 49.
    • (2008) Dig J Nanomat Biostruct. , vol.3 , pp. 49
    • Mishra, M.1    Kumar, H.2    Tripathi, K.3
  • 102
    • 16344392040 scopus 로고    scopus 로고
    • Cellular fate of a modular DNA delivery system mediated by silica nanoparticles
    • Gemeinhart RA, Luo D, Saltzman WM. Cellular fate of a modular DNA delivery system mediated by silica nanoparticles. Biotechnol Prog. 2005; 21: 532-7.
    • (2005) Biotechnol Prog. , vol.21 , pp. 532-537
    • Gemeinhart, R.A.1    Luo, D.2    Saltzman, W.M.3
  • 103
    • 46749123819 scopus 로고    scopus 로고
    • Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers
    • Slowing II, Vivero-Escoto JL, Wu C, Lin VS. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev. 2008; 60: 1278-88.
    • (2008) Adv Drug Deliv Rev. , vol.60 , pp. 1278-1288
    • Slowing, I.I.1    Vivero-Escoto, J.L.2    Wu, C.3    Lin, V.S.4
  • 105
    • 15944411007 scopus 로고    scopus 로고
    • Large-scale synthesis of uniform and crystalline magnetite nanoparticles using reverse micelles as nanoreactors under reflux conditions
    • Lee Y, Lee J, Bae CJ, Park JG, Noh HJ, Park JH, Hyeon T. Large-scale synthesis of uniform and crystalline magnetite nanoparticles using reverse micelles as nanoreactors under reflux conditions. Adv Funct Mater. 2005; 15: 503-9.
    • (2005) Adv Funct Mater. , vol.15 , pp. 503-509
    • Lee, Y.1    Lee, J.2    Bae, C.J.3    Park, J.G.4    Noh, H.J.5    Park, J.H.6    Hyeon, T.7
  • 106
    • 34247179477 scopus 로고    scopus 로고
    • Magnetic nanoparticles: Synthesis, protection, functionalization, and application
    • Lu AH, Salabas EL, Schuth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed. 2007; 46: 1222-44.
    • (2007) Angew Chem Int Ed. , vol.46 , pp. 1222-1244
    • Lu, A.H.1    Salabas, E.L.2    Schuth, F.3
  • 107
    • 73249135370 scopus 로고    scopus 로고
    • Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: Account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR Images
    • Park JY, Baek MJ, Choi ES, Woo S, Kim JH, Kim TJ, Jung JC, Chae KS, Chang Y, Lee GH. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR Images. ACS Nano. 2009; 3: 3663-9.
    • (2009) ACS Nano. , vol.3 , pp. 3663-3669
    • Park, J.Y.1    Baek, M.J.2    Choi, E.S.3    Woo, S.4    Kim, J.H.5    Kim, T.J.6    Jung, J.C.7    Chae, K.S.8    Chang, Y.9    Lee, G.H.10
  • 108
    • 80051721541 scopus 로고    scopus 로고
    • Size-tunable, ultrasmall NaGdF4 nanoparticles: Insights into their T1 MRI contrast enhancement
    • Johnson NJJ, Oakden W, Stanisz GJ, Prosser RS, van Veggel FCJM. Size-tunable, ultrasmall NaGdF4 nanoparticles: insights into their T1 MRI contrast enhancement. Chem Mater. 2011; 23: 3714-22.
    • (2011) Chem Mater. , vol.23 , pp. 3714-3722
    • Johnson, N.J.J.1    Oakden, W.2    Stanisz, G.J.3    Prosser, R.S.4    van Veggel, F.C.J.M.5
  • 109
    • 64249102030 scopus 로고    scopus 로고
    • Combined optical and MR bioimaging using rare earth ion doped NaYF4 nanocrystals
    • Kumar R, Nyk M, Ohulchansky TY, Flask CA, Prasad PN. Combined optical and MR bioimaging using rare earth ion doped NaYF4 nanocrystals. Adv Funct Mater. 2009; 19: 853-9.
    • (2009) Adv Funct Mater. , vol.19 , pp. 853-859
    • Kumar, R.1    Nyk, M.2    Ohulchansky, T.Y.3    Flask, C.A.4    Prasad, P.N.5
  • 110
    • 3042689597 scopus 로고    scopus 로고
    • Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: Implications for magnetic resonance imaging
    • Briley-Saebo K, Bjornerud A, Grant D, Ahlstrom H, Berg T, Kindberg GM. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging. Cell Tissue Res. 2004; 316: 315-23.
    • (2004) Cell Tissue Res. , vol.316 , pp. 315-323
    • Briley-Saebo, K.1    Bjornerud, A.2    Grant, D.3    Ahlstrom, H.4    Berg, T.5    Kindberg, G.M.6
  • 111
    • 0035058159 scopus 로고    scopus 로고
    • Radiolabeling of magnetic particles with rhenium-188 for cancer therapy
    • Hafeli U, Pauer G, Failing S, Tapolsky G. Radiolabeling of magnetic particles with rhenium-188 for cancer therapy. J Magn Mater. 2001; 225: 73-8.
    • (2001) J Magn Mater. , vol.225 , pp. 73-78
    • Hafeli, U.1    Pauer, G.2    Failing, S.3    Tapolsky, G.4
  • 113
    • 0023753617 scopus 로고
    • Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration
    • Alberts DS, Surwit EA, Peng YM, McCloskey T, Rivest R, Graham V. Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration. Cancer Res. 1988; 48: 5874-7.
    • (1988) Cancer Res. , vol.48 , pp. 5874-5877
    • Alberts, D.S.1    Surwit, E.A.2    Peng, Y.M.3    McCloskey, T.4    Rivest, R.5    Graham, V.6
  • 114
    • 77952775122 scopus 로고    scopus 로고
    • Improving the anti-tumor effect of genistein with a biocompatible super paramagnetic drug delivery system
    • Si HY, Li DP, Wang TM, Zhang HL, Ran FY, Cu ZG, Zhao YY. Improving the anti-tumor effect of genistein with a biocompatible super paramagnetic drug delivery system. J Nanosci Nanotechnol. 2010; 10: 2325-31.
    • (2010) J Nanosci Nanotechnol. , vol.10 , pp. 2325-2331
    • Si, H.Y.1    Li, D.P.2    Wang, T.M.3    Zhang, H.L.4    Ran, F.Y.5    Cu, Z.G.6    Zhao, Y.Y.7
  • 115
    • 34250217742 scopus 로고    scopus 로고
    • Development of hyaluronic acid-Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides
    • Kumar A, Sahoo B, Montpetit A, Behera S, Lockey RF, Mohapatra SS. Development of hyaluronic acid-Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides. Nanomedicine. 2007; 3: 132-7.
    • (2007) Nanomedicine. , vol.3 , pp. 132-137
    • Kumar, A.1    Sahoo, B.2    Montpetit, A.3    Behera, S.4    Lockey, R.F.5    Mohapatra, S.S.6
  • 116
    • 4644237609 scopus 로고    scopus 로고
    • Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy
    • Voura EB, Jaiswal JK, Mattoussi H, Simon SM. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat Med. 2004; 10: 993-8.
    • (2004) Nat Med. , vol.10 , pp. 993-998
    • Voura, E.B.1    Jaiswal, J.K.2    Mattoussi, H.3    Simon, S.M.4
  • 118
    • 33646126929 scopus 로고    scopus 로고
    • A rapid and transient ROS generation by cadmium triggers apoptosis via caspasedependent pathway in HepG2 cells and this is inhibited through N-acetylcysteine-mediated catalase up regulation
    • Oh SH, Lim SC. A rapid and transient ROS generation by cadmium triggers apoptosis via caspasedependent pathway in HepG2 cells and this is inhibited through N-acetylcysteine-mediated catalase up regulation. Toxicol Appl Pharmacol. 2006; 212: 212-23.
    • (2006) Toxicol Appl Pharmacol. , vol.212 , pp. 212-223
    • Oh, S.H.1    Lim, S.C.2
  • 121
    • 77953396630 scopus 로고    scopus 로고
    • Fluorescent silica nanoparticles for cancer imaging
    • Santra S. Fluorescent silica nanoparticles for cancer imaging. Methods Mol Biol. 2010; 624: 151-62.
    • (2010) Methods Mol Biol. , vol.624 , pp. 151-162
    • Santra, S.1
  • 122
    • 33745727326 scopus 로고    scopus 로고
    • Preparation and characterization of novel CdSe quantum dots modified with poly (d, l-lactide) nanoparticles
    • Guo G, Liu W, Liang J, Xu H, He Z, Yang X. Preparation and characterization of novel CdSe quantum dots modified with poly (d, l-lactide) nanoparticles. Mater Lett. 2006; 60: 2565-8.
    • (2006) Mater Lett. , vol.60 , pp. 2565-2568
    • Guo, G.1    Liu, W.2    Liang, J.3    Xu, H.4    He, Z.5    Yang, X.6
  • 123
    • 16444369966 scopus 로고    scopus 로고
    • Preparation and evaluation of poly (L-lactide-co-glycolide) (PLGA) microbubbles as a contrast agent for myocardial contrast echocardiography
    • Cui W, Bei J, Wang S, Zhi G, Zhao Y, Zhou X, Zhang H, Xu Y. Preparation and evaluation of poly (L-lactide-co-glycolide) (PLGA) microbubbles as a contrast agent for myocardial contrast echocardiography. J Biomed Mater Res B Appl Biomater. 2005; 73: 171-8.
    • (2005) J Biomed Mater Res B Appl Biomater. , vol.73 , pp. 171-178
    • Cui, W.1    Bei, J.2    Wang, S.3    Zhi, G.4    Zhao, Y.5    Zhou, X.6    Zhang, H.7    Xu, Y.8
  • 124
    • 33749511606 scopus 로고    scopus 로고
    • Comparison of in vitro and in vivo acoustic response of a novel 50: 50 PLGA contrast agent
    • Wheatley MA, Forsberg F, Oum K, Ro R, El-Sherif D. Comparison of in vitro and in vivo acoustic response of a novel 50: 50 PLGA contrast agent. Ultrasonics. 2006; 44: 360-7.
    • (2006) Ultrasonics. , vol.44 , pp. 360-367
    • Wheatley, M.A.1    Forsberg, F.2    Oum, K.3    Ro, R.4    El-Sherif, D.5
  • 125
    • 0028889369 scopus 로고
    • In vitro identification of vasoactive intestinal peptide receptors in human tumors: Implications for tumor imaging
    • Reubi JC. In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging. J Nucl Med. 1995; 36: 1846-53.
    • (1995) J Nucl Med. , vol.36 , pp. 1846-1853
    • Reubi, J.C.1
  • 126
    • 4243089402 scopus 로고    scopus 로고
    • Persistent contrast enhancement by sterically stabilized paramagnetic liposomes in murine melanoma
    • Bertini I, Bianchini F, Calorini L, Colagrande S, Fragai M, Franchi A. Persistent contrast enhancement by sterically stabilized paramagnetic liposomes in murine melanoma. Magn Reson Med. 2004; 52: 669-72.
    • (2004) Magn Reson Med. , vol.52 , pp. 669-672
    • Bertini, I.1    Bianchini, F.2    Calorini, L.3    Colagrande, S.4    Fragai, M.5    Franchi, A.6
  • 127
    • 0037345827 scopus 로고    scopus 로고
    • Macromolecular MRI contrast agents with small dendrimers: Pharmacokinetic differences between sizes and cores
    • Kobayashi H, Kawamoto S, Jo SK, Bryant Jr HL, Brechbiel MW, Star RA. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. Bioconjug Chem. 2003; 14: 388-94.
    • (2003) Bioconjug Chem. , vol.14 , pp. 388-394
    • Kobayashi, H.1    Kawamoto, S.2    Jo, S.K.3    Bryant Jr., H.L.4    Brechbiel, M.W.5    Star, R.A.6
  • 128
  • 129
    • 0141813385 scopus 로고    scopus 로고
    • Characteristics of a new MRI contrast agent prepared from polypropyleneimine dendrimers, generation 2
    • Wang SJ, Brechbiel M, Wiener EC. Characteristics of a new MRI contrast agent prepared from polypropyleneimine dendrimers, generation 2. Invest Radiol. 2003; 38: 662-8.
    • (2003) Invest Radiol. , vol.38 , pp. 662-668
    • Wang, S.J.1    Brechbiel, M.2    Wiener, E.C.3
  • 130
    • 0036899037 scopus 로고    scopus 로고
    • Biological applications of dendrimers
    • Cloninger MJ. Biological applications of dendrimers. Curr Opin Chem Biol. 2002; 6: 742-8.
    • (2002) Curr Opin Chem Biol. , vol.6 , pp. 742-748
    • Cloninger, M.J.1
  • 131
    • 0036181219 scopus 로고    scopus 로고
    • Design and synthesis of glycodendrimers
    • Turnbull WB, Stoddart JF. Design and synthesis of glycodendrimers. J Biotechnol. 2002; 90: 231-55.
    • (2002) J Biotechnol. , vol.90 , pp. 231-255
    • Turnbull, W.B.1    Stoddart, J.F.2
  • 132
    • 5644254184 scopus 로고    scopus 로고
    • Dendritic macromers as in situ polymerizing biomaterials for securing cataract incisions
    • Wathier M, Jung PJ, Carnahan MA, Kim T, Grinstaff MW. Dendritic macromers as in situ polymerizing biomaterials for securing cataract incisions. J Am Chem Soc. 2004; 126: 12744-5.
    • (2004) J Am Chem Soc. , vol.126 , pp. 12744-12745
    • Wathier, M.1    Jung, P.J.2    Carnahan, M.A.3    Kim, T.4    Grinstaff, M.W.5
  • 133
    • 0037007875 scopus 로고    scopus 로고
    • Biodendrimers: New polymeric biomaterials for tissue engineering
    • Grinstaff MW. Biodendrimers: new polymeric biomaterials for tissue engineering. Chemistry. 2002; 8: 2839-46.
    • (2002) Chemistry. , vol.8 , pp. 2839-2846
    • Grinstaff, M.W.1
  • 134
    • 77955247993 scopus 로고    scopus 로고
    • A novel poly (l-glutamic acid) dendrimer based drug delivery system with both pH sensitive and targeting functions
    • Yuan H, Luo K, Lai Y, Pu Y, He B, Wang G. A novel poly (l-glutamic acid) dendrimer based drug delivery system with both pH sensitive and targeting functions. Mol Pharm. 2010; 7: 953-62.
    • (2010) Mol Pharm. , vol.7 , pp. 953-962
    • Yuan, H.1    Luo, K.2    Lai, Y.3    Pu, Y.4    He, B.5    Wang, G.6
  • 136
    • 11944272030 scopus 로고    scopus 로고
    • Solubility enhancement of indomethacin with poly (amidoamine) dendrimers and targeting to inflammatory regions of arthritic rats
    • Chauhan AS, Jain NK, Diwan PV, Khopade AJ. Solubility enhancement of indomethacin with poly (amidoamine) dendrimers and targeting to inflammatory regions of arthritic rats. J Drug Target. 2004; 12: 575-83.
    • (2004) J Drug Target. , vol.12 , pp. 575-583
    • Chauhan, A.S.1    Jain, N.K.2    Diwan, P.V.3    Khopade, A.J.4
  • 138
    • 1542511346 scopus 로고    scopus 로고
    • Evaluation of generation 2 and 3 poly (propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor
    • Hollins AJ, Benboubetra M, Omidi Y, Zinselmeyer BH, Schatzlein AG, Uchegbu. Evaluation of generation 2 and 3 poly (propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor. Pharm Res. 2004; 21: 458-66.
    • (2004) Pharm Res. , vol.21 , pp. 458-466
    • Hollins, A.J.1    Benboubetra, M.2    Omidi, Y.3    Zinselmeyer, B.H.4    Schatzlein, A.G.5    Uchegbu6
  • 140
    • 23844531202 scopus 로고    scopus 로고
    • Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction
    • Kam NW, O'Connell M, Wisdom JA, Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci USA. 2005; 102: 11600-5.
    • (2005) Proc Natl Acad Sci USA. , vol.102 , pp. 11600-11605
    • Kam, N.W.1    O'Connell, M.2    Wisdom, J.A.3    Dai, H.4
  • 141
    • 33750159066 scopus 로고    scopus 로고
    • Applications of carbon nanotubes-based biomaterials in biomedical nanotechnology
    • Polizu, S. Savadogo, O, Poulin P. Applications of carbon nanotubes-based biomaterials in biomedical nanotechnology. J Nanosci Nanotechnol. 2006; 6: 1883-904.
    • (2006) J Nanosci Nanotechnol. , vol.6 , pp. 1883-1904
    • Polizu, S.1    Savadogo, O.2    Poulin, P.3
  • 142
    • 84859839124 scopus 로고    scopus 로고
    • Vitamin E TPGS as a molecular biomaterial for drug delivery
    • Zhang Z, Tan S, Feng SS. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials. 2012; 33: 4889-906.
    • (2012) Biomaterials. , vol.33 , pp. 4889-4906
    • Zhang, Z.1    Tan, S.2    Feng, S.S.3
  • 143
  • 145
    • 84867658694 scopus 로고    scopus 로고
    • Epigenetics advancing personalized nanomedicine in cancer therapy
    • Shujun Liu. Epigenetics advancing personalized nanomedicine in cancer therapy. Adv Drug Deliv Rev. 2012; 64: 1532-43.
    • (2012) Adv Drug Deliv Rev. , vol.64 , pp. 1532-1543
    • Liu, S.1
  • 147
    • 0030895036 scopus 로고    scopus 로고
    • Oral peptide delivery using nanoparticles composed of novel graft copolymers having hydrophobic backbone and hydrophilic branches
    • Sakuma S, Suzuki N, Kikuchi H, Arikawa KHK, Kishida A, Akashi M. Oral peptide delivery using nanoparticles composed of novel graft copolymers having hydrophobic backbone and hydrophilic branches. Int J Pharm. 1997; 149: 93-106.
    • (1997) Int J Pharm. , vol.149 , pp. 93-106
    • Sakuma, S.1    Suzuki, N.2    Kikuchi, H.3    Arikawa, K.H.K.4    Kishida, A.5    Akashi, M.6
  • 148
    • 0027590737 scopus 로고
    • Nano-and microparticles for the delivery of polypeptides and proteins
    • Couvreur P, Puisieux F. Nano-and microparticles for the delivery of polypeptides and proteins. Adv Drug Deliv Rev. 1993; 10: 141-62.
    • (1993) Adv Drug Deliv Rev. , vol.10 , pp. 141-162
    • Couvreur, P.1    Puisieux, F.2
  • 150
    • 0035937595 scopus 로고    scopus 로고
    • Nanoparticulate systems for brain delivery of drugs
    • Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev. 2001; 47: 65-81.
    • (2001) Adv Drug Deliv Rev. , vol.47 , pp. 65-81
    • Kreuter, J.1
  • 151
    • 6344258939 scopus 로고    scopus 로고
    • Drug delivery to the brain-realization by novel drug carriers
    • Muller RH, Keck CM. Drug delivery to the brain-realization by novel drug carriers. J Nanosci Nanotechnol. 2004; 4: 471.
    • (2004) J Nanosci Nanotechnol. , vol.4 , pp. 471
    • Muller, R.H.1    Keck, C.M.2
  • 152
    • 80052762003 scopus 로고    scopus 로고
    • Nanotechnology in ocular delivery: Current and future directions
    • Sultana Y, Maurya DP, Iqbal Z, Aqil M. Nanotechnology in ocular delivery: current and future directions. Drugs Today. 2011; 47: 441-55.
    • (2011) Drugs Today. , vol.47 , pp. 441-455
    • Sultana, Y.1    Maurya, D.P.2    Iqbal, Z.3    Aqil, M.4
  • 154
    • 33646865219 scopus 로고    scopus 로고
    • Novel therapeutic gene regulation by genetic biosensor tethered to magnetic nanoparticles for the detection and treatment of retinopathy of prematurity
    • Prow TW, Grebe R, Merges C, Smith JN, D. McLeod S, Leary JF, Lutty GA. Novel therapeutic gene regulation by genetic biosensor tethered to magnetic nanoparticles for the detection and treatment of retinopathy of prematurity. Mol Vis. 2006; 12: 616-25.
    • (2006) Mol Vis. , vol.12 , pp. 616-625
    • Prow, T.W.1    Grebe, R.2    Merges, C.3    Smith, J.N.D.4    McLeod, S.5    Leary, J.F.6    Lutty, G.A.7
  • 156
    • 13844267655 scopus 로고    scopus 로고
    • Dispersion of microemulsion drops in HEMA hydrogel: A potential ophthalmic drug delivery vehicle
    • Gulsen D, Chauhan A. Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle. Int J Pharm. 2005; 292: 95-117.
    • (2005) Int J Pharm. , vol.292 , pp. 95-117
    • Gulsen, D.1    Chauhan, A.2
  • 157
    • 77956937545 scopus 로고    scopus 로고
    • Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery
    • Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery. Drug Dev Ind Pharm. 2010; 36: 1330-9.
    • (2010) Drug Dev Ind Pharm. , vol.36 , pp. 1330-1339
    • Ammar, H.O.1    Salama, H.A.2    Ghorab, M.3    Mahmoud, A.A.4
  • 159
    • 77955049646 scopus 로고    scopus 로고
    • Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability
    • Gan, L. Han S, Shen J, Zhu J, Zhu C, Zhang X, Gan Y. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability. Int J Pharm. 2010; 396: 179-87.
    • (2010) Int J Pharm. , vol.396 , pp. 179-187
    • Gan, L.1    Han, S.2    Shen, J.3    Zhu, J.4    Zhu, C.5    Zhang, X.6    Gan, Y.7
  • 160
    • 78650687509 scopus 로고    scopus 로고
    • Potential of new nanocarriers for dermal and transdermal drug delivery
    • Neubert RHH. Potential of new nanocarriers for dermal and transdermal drug delivery. Eur J Pharm. 2011; 77: 1-2.
    • (2011) Eur J Pharm. , vol.77 , pp. 1-2
    • Neubert, R.H.H.1
  • 161
    • 0029859574 scopus 로고    scopus 로고
    • Fusigenic viral liposome for gene therapy in cardiovascular diseases
    • Dzau VJ, Mann MJ, Morishita R, Kaneda Y. Fusigenic viral liposome for gene therapy in cardiovascular diseases. Proc Nat Acad Sci USA. 1996; 93: 11421-5.
    • (1996) Proc Nat Acad Sci USA. , vol.93 , pp. 11421-11425
    • Dzau, V.J.1    Mann, M.J.2    Morishita, R.3    Kaneda, Y.4
  • 163
    • 82255162972 scopus 로고    scopus 로고
    • Nanomedicine approaches in vascular disease: A review
    • Gupta AS. Nanomedicine approaches in vascular disease: a review. Nanomedicine. 2011; 7: 763-79.
    • (2011) Nanomedicine. , vol.7 , pp. 763-779
    • Gupta, A.S.1
  • 164
    • 84870622162 scopus 로고    scopus 로고
    • Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration
    • Chung E, Ricles LM, Stowers RS, Nam SY, Emelianov SY, Suggs JL. Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration. Nano Today. 2012; 7: 514-31.
    • (2012) Nano Today. , vol.7 , pp. 514-531
    • Chung, E.1    Ricles, L.M.2    Stowers, R.S.3    Nam, S.Y.4    Emelianov, S.Y.5    Suggs, J.L.6
  • 165
    • 44349108852 scopus 로고    scopus 로고
    • Peptide amphiphile nanostructure-heparin interactions and their relationship to bioactivity
    • Rajangam K, Arnold MS, Rocco MA, Stupp SI. Peptide amphiphile nanostructure-heparin interactions and their relationship to bioactivity. Biomaterials. 2008; 29: 3298-305.
    • (2008) Biomaterials. , vol.29 , pp. 3298-3305
    • Rajangam, K.1    Arnold, M.S.2    Rocco, M.A.3    Stupp, S.I.4
  • 166
    • 36549018670 scopus 로고    scopus 로고
    • Safety and efficacy of amphiphilic ß-cyclodextrin nanoparticles for paclitaxel delivery
    • Bilensoy E, Gurkaynak O, Do Gan AL, Hi{dotless}ncal AA. Safety and efficacy of amphiphilic ß-cyclodextrin nanoparticles for paclitaxel delivery. Int J Pharm. 2008; 347: 163-70.
    • (2008) Int J Pharm. , vol.347 , pp. 163-170
    • Bilensoy, E.1    Gurkaynak, O.2    Do Gan, A.L.3    Hincal, A.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.